HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.
Headshot of Dr. Set Berk

Seth H. Berk, MD

Board Certifications: Hematology, Internal Medicine and Medical Oncology

Languages: English

Locations: Moorestown, NJ

Dr Berk, who practices in Moorestown, has treated patients in this southern NJ community for more than 20 years.  He is actively involved in enrolling patients in clinical trials.  Dr. Berk is the Section Chief of Hematology/Oncology at Virtua Memorial Hospital.  While completing his fellowship, he was involved in clinical and laboratory research, where his focus was on the development of new chemotherapy agents to treat a variety of cancers.

Education

Medical Education

Columbia University College of Physicians and Surgeons

Residency

Columbia Presbyterian Medical Center, residency in internal medicine

fellowship

University of Chicago, fellowship in hematology and oncology

Awards and honors

Awards and honors

  • Castle Connolly Regional Top Doctors: 1st Edition
  • Jersey’s Best Magazine Top Doctors: 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2022, 2023, 2024
  • Jersey’s Best Magazine Top Doctors for Cancer: 2022, 2023, 2024
  • Philadelphia Magazine: 2018, 2019, 2020, 2021, 2022, 2023
  • Philadelphia Magazine – Cancer Doctors: 2020
  • South Jersey Magazine’s Top Physicians for Women: 2022
  • South Jersey Magazine’s Top Doctor (patient poll): 2022
  • Suburban Family Magazine Five Star Physician: 2022

Professional Memberships

Medical Society of New Jersey, American Society of Clinical Oncology, American Society of Hematology

Hospital Affiliations

Virtua Memorial Hospital

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.